Filing Details
- Accession Number:
- 0001209191-15-066077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-14 16:26:20
- Reporting Period:
- 2015-08-12
- Filing Date:
- 2015-08-14
- Accepted Time:
- 2015-08-14 16:26:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1371217 | Enteromedics Inc | ETRM | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1243513 | B Mark Knudson | 2800 Patton Road St. Paul MN 55113 | Chrmn, Pres & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-12 | 135,000 | $0.24 | 135,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-08-13 | 168,000 | $0.25 | 303,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,382 | Indirect | Spouse Revocable Trust |
Common Stock | 3,215 | Indirect | Family Limited Partnership |
Common Stock | 57,571 | Indirect | Revocable Trust 2003 |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $2.76 | 2015-04-27 | 7,915 | 7,915 | Direct | |
Common Stock | Stock Option (right to buy) | $2.76 | 2016-04-20 | 6,776 | 6,776 | Direct | |
Common Stock | Stock Option (right to buy) | $1.90 | 2010-10-29 | 2017-10-29 | 33,432 | 33,432 | Direct |
Common Stock | Stock Option (right to buy) | $1.90 | 2010-10-29 | 2017-10-29 | 25,902 | 25,902 | Direct |
Common Stock | Stock Option (right to buy) | $1.90 | 2010-10-29 | 2017-10-29 | 44,131 | 44,131 | Direct |
Common Stock | Stock Option (right to buy) | $1.90 | 2010-10-29 | 2017-10-29 | 50,472 | 50,472 | Direct |
Common Stock | Stock Option (right to buy) | $3.78 | 2019-11-18 | 20,833 | 20,833 | Direct | |
Common Stock | Warrant (common stock right to buy) | $2.19 | 25,000 | 25,000 | Direct | ||
Common Stock | Stock Option (right to buy) | $2.58 | 2011-03-16 | 2021-02-16 | 350,000 | 350,000 | Direct |
Common Stock | Stock Option (right to buy) | $2.67 | 2011-08-12 | 2021-07-12 | 350,000 | 350,000 | Direct |
Common Stock | Stock Option (right to buy) | $1.90 | 2012-01-14 | 2021-12-14 | 200,000 | 200,000 | Direct |
Common Stock | Stock Option (right to buy) | $3.35 | 2012-08-10 | 2022-07-10 | 1,292,225 | 1,292,225 | Direct |
Common Stock | Stock Option (right to buy) | $1.31 | 2013-06-30 | 2013-05-31 | 1,278,730 | 1,278,730 | Direct |
Common Stock | Stock Option (right to buy) | $1.11 | 2015-04-09 | 2025-03-09 | 225,000 | 225,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2015-04-27 | 7,915 | 7,915 | Direct |
2016-04-20 | 6,776 | 6,776 | Direct |
2017-10-29 | 33,432 | 33,432 | Direct |
2017-10-29 | 25,902 | 25,902 | Direct |
2017-10-29 | 44,131 | 44,131 | Direct |
2017-10-29 | 50,472 | 50,472 | Direct |
2019-11-18 | 20,833 | 20,833 | Direct |
25,000 | 25,000 | Direct | |
2021-02-16 | 350,000 | 350,000 | Direct |
2021-07-12 | 350,000 | 350,000 | Direct |
2021-12-14 | 200,000 | 200,000 | Direct |
2022-07-10 | 1,292,225 | 1,292,225 | Direct |
2013-05-31 | 1,278,730 | 1,278,730 | Direct |
2025-03-09 | 225,000 | 225,000 | Direct |
Footnotes
- The price reported is the weighted average purchase price for the transaction reported. The purchase prices ranged from $0.2349 to $0.2500. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.
- The price reported is the weighted average purchase price for the transaction reported. The purchase prices ranged from $0.2475 to $0.2490. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.
- Options currently 100% vested.
- Options vest 33% on date noted and thereafter at 1/24th per month.
- Warrant becomes exercisable 181 days from the date of issuance at close of offering.
- Warrant expires five years from the date it becomes exercisable.
- Vests in increments of 1/48th per month, beginning the date shown.
- The exercise price is the closing price on July 10, 2012, the date the board authorized the grants subject to stockholder approval of the increase in the number of shares available for awards under the incentive plan, which was obtained on September 27, 2012.